HighTower Advisors LLC Sells 5,176 Shares of Cigna Group $CI

HighTower Advisors LLC lessened its holdings in Cigna Group (NYSE:CI) by 6.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 72,695 shares of the health services provider’s stock after selling 5,176 shares during the quarter. HighTower Advisors LLC’s holdings in Cigna Group were worth $20,008,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in the business. Vanguard Group Inc. lifted its position in shares of Cigna Group by 1.6% in the fourth quarter. Vanguard Group Inc. now owns 26,173,577 shares of the health services provider’s stock worth $7,203,754,000 after purchasing an additional 414,834 shares in the last quarter. Massachusetts Financial Services Co. MA raised its position in Cigna Group by 8.3% during the fourth quarter. Massachusetts Financial Services Co. MA now owns 11,805,083 shares of the health services provider’s stock worth $3,249,113,000 after acquiring an additional 903,334 shares in the last quarter. Dodge & Cox raised its position in Cigna Group by 4.0% during the third quarter. Dodge & Cox now owns 9,305,225 shares of the health services provider’s stock worth $2,682,231,000 after acquiring an additional 354,615 shares in the last quarter. Sanders Capital LLC raised its position in Cigna Group by 0.5% during the third quarter. Sanders Capital LLC now owns 7,828,168 shares of the health services provider’s stock worth $2,256,469,000 after acquiring an additional 35,150 shares in the last quarter. Finally, Capital Research Global Investors raised its position in Cigna Group by 140.2% during the third quarter. Capital Research Global Investors now owns 3,179,301 shares of the health services provider’s stock worth $916,434,000 after acquiring an additional 1,855,897 shares in the last quarter. Institutional investors own 86.99% of the company’s stock.

Cigna Group Price Performance

NYSE:CI opened at $286.06 on Friday. Cigna Group has a one year low of $239.51 and a one year high of $338.89. The company has a market cap of $75.67 billion, a P/E ratio of 12.13, a P/E/G ratio of 1.00 and a beta of 0.30. The firm’s fifty day moving average price is $276.63 and its two-hundred day moving average price is $276.10. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.73 and a quick ratio of 0.73.

Cigna Group (NYSE:CI) last released its quarterly earnings data on Thursday, April 30th. The health services provider reported $7.79 EPS for the quarter, beating the consensus estimate of $7.60 by $0.19. Cigna Group had a net margin of 2.26% and a return on equity of 19.75%. The firm had revenue of $68.52 billion for the quarter, compared to the consensus estimate of $66.29 billion. During the same period in the previous year, the company earned $6.74 earnings per share. The company’s quarterly revenue was up 4.6% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.350- EPS. Equities analysts expect that Cigna Group will post 30.39 earnings per share for the current year.

Cigna Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, June 18th. Shareholders of record on Thursday, June 4th will be issued a $1.56 dividend. This represents a $6.24 annualized dividend and a dividend yield of 2.2%. The ex-dividend date is Thursday, June 4th. Cigna Group’s payout ratio is currently 26.45%.

Insider Buying and Selling at Cigna Group

In other Cigna Group news, CEO David Cordani sold 201,878 shares of the company’s stock in a transaction on Tuesday, May 12th. The shares were sold at an average price of $292.82, for a total value of $59,113,915.96. Following the transaction, the chief executive officer directly owned 34,337 shares in the company, valued at $10,054,560.34. The trade was a 85.46% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Everett Neville sold 1,719 shares of the company’s stock in a transaction on Monday, March 2nd. The shares were sold at an average price of $288.91, for a total transaction of $496,636.29. Following the completion of the transaction, the insider owned 5,670 shares in the company, valued at approximately $1,638,119.70. This represents a 23.26% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 205,904 shares of company stock worth $60,277,068 over the last ninety days. Insiders own 0.60% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on the stock. Jefferies Financial Group dropped their price target on shares of Cigna Group from $333.00 to $330.00 and set a “buy” rating on the stock in a research report on Monday, April 20th. Leerink Partners upped their price target on shares of Cigna Group from $270.00 to $297.00 and gave the stock a “market perform” rating in a research report on Friday, February 6th. Truist Financial upped their price target on shares of Cigna Group from $320.00 to $350.00 and gave the stock a “buy” rating in a research report on Tuesday, February 17th. Royal Bank Of Canada upped their price target on shares of Cigna Group from $333.00 to $337.00 and gave the stock an “outperform” rating in a research report on Friday, May 1st. Finally, Raymond James Financial set a $340.00 price target on shares of Cigna Group in a research report on Friday, May 1st. One investment analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and five have issued a Hold rating to the company. Based on data from MarketBeat.com, Cigna Group currently has an average rating of “Moderate Buy” and an average price target of $339.80.

Cigna Group Company Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.